Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.

Keywords : ["type diabetes mellitus inadequately control", "metformin alone longterm extension", "randomise control trial", "saxagliptin vs glipizide", "addon therapy", "patient"]
Author : Fist_Author_Year_PM
105

Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: a double-blind randomised clinical trial.

Keywords : ["overweight type diabetes mellitus patient", "eicosapentaenoic acid improve insulin sensitivity", "doubleblind randomise clinical trial", "blood sugar"]
Author : Fist_Author_Year_PM
109

Usage of glucometer is associated with improved glycaemic control in type 2 diabetes mellitus patients in Malaysian public primary care clinics: an open-label, randomised controlled trial.

Keywords : ["malaysian public primary care clinic", "type diabetes mellitus patient", "openlabel randomise control trial", "improved glycaemic control", "usage", "glucometer", "associate"]
Author : Fist_Author_Year_PM
107

Status of stem cell based clinical trials in the treatment for diabetes.

Keywords : ["stem cell base clinical trial", "treatment", "status", "diabetes"]
Author : Fist_Author_Year_PM
113

Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function.

Keywords : ["inflammation oxidative stress insulin resistance", "randomised control study effect", "type diabetes", "endothelial function", "different dose", "aspirin"]
Author : Fist_Author_Year_PM
109

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.

Keywords : ["randomised doubleblind placebocontrolle trial", "exist antidiabete treatment", "chronic kidney disease", "type diabetes", "empagliflozin add", "safety", "patient", "efficacy"]
Author : Fist_Author_Year_PM
110

The SimpleMix study with biphasic insulin aspart 30: a randomized controlled trial investigating patient-driven titration versus investigator-driven titration.

Keywords : ["randomized control trial investigate patientdriven titration versus investigatordriven titration", "biphasic insulin aspart", "simplemix study"]
Author : Fist_Author_Year_PM
109

Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial.

Keywords : ["randomized double blind clinical trial", "low dose pioglitazone", "type diabetes", "insulin resistance", "glycemic control", "effect"]
Author : Fist_Author_Year_PM
109

The benefits and risks of DPP4-inhibitors vs. sulfonylureas for patients with type 2 diabetes: accumulated evidence from randomised controlled trial.

Keywords : ["type diabetes accumulate evidence", "randomised control trial", "vs sulfonylureas", "risk", "patient", "benefit"]
Author : Fist_Author_Year_PM
108

Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials.

Keywords : ["onceweekly glucagonlike receptor agonist compare", "randomised control trial", "type diabetes", "systemic review", "safety", "liraglutide", "exenatide", "efficacy"]
Author : Fist_Author_Year_PM
107